Sugi Predict

Sugi Predict / Compounds / SCHEMBL30980522

SCHEMBL30980522

SCHEMBL30980522

CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1CCCCCOCCOCCNC(=O)NCCCOCC(N)(COCCCNC(=O)NCCOCCOCCCCC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)COCCCNC(=O)NCCOCCOCCCCC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.43
▸ MDK P21741 1/20 0.37
▸ LGALS8 O00214 1/20 0.36
▸ LGALS3 P17931 1/20 0.36
▸ LGALS4 P56470 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ OGA O60502 2/20 0.33
▸ B4GALT1 P15291 1/20 0.33
▸ CD69 Q07108 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HEXB P07686 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980516 0.90 MDK (0.45) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980709 0.88 MAPK1 (0.41) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980606 0.88 MAPK1 (0.47) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980751 0.86 MDK (0.44) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980757 0.85 MAPK1 (0.46) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980790 0.85 MAPK1 (0.44) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980642 0.84 MAPK1 (0.43) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980707 0.83 MAPK1 (0.43) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL30980704 0.82 MAPK1 (0.52) MAPK1MDKLGALS8LGALS3LGALS4
SCHEMBL31384238 0.81 MAPK1 (0.53) MAPK1LGALS8LGALS3LGALS4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651904-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF AUTOANTIBODIES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
WO-2024155750-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback